Full Name
CHIN TAN MIN
Variants
Chin, T.-M.
Chin, T.M.
 
 
 
Email
csictm@nus.edu.sg
 

Publications

Results 1-12 of 12 (Search time: 0.002 seconds).

Issue DateTitleAuthor(s)
1Apr-2012A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancerNg, K.P.; Hillmer, A.M.; Chuah, C.T.H.; Juan, W.C.; Ko, T.K. ; Teo, A.S.M.; Ariyaratne, P.N.; Takahashi, N.; Sawada, K.; Fei, Y.; Soh, S.; Lee, W.H.; Huang, J.W.J.; Allen Jr., J.C.; Woo, X.Y.; Nagarajan, N.; Kumar, V.; Thalamuthu, A.; Poh, W.T.; Ang, A.L.; Mya, H.T.; How, G.F.; Yang, L.Y.; Koh, L.P.; Chowbay, B.; Chang, C.-T.; Nadarajan, V.S.; Chng, W.J.; Than, H.; Lim, L.C.; Goh, Y.T.; Zhang, S.; Poh, D.; Tan, P. ; Seet, J.-E.; Ang, M.-K.; Chau, N.-M.; Ng, Q.-S.; Tan, D.S.W.; Soda, M.; Isobe, K.; Nöthen, M.M.; Wong, T.Y. ; Shahab, A.; Ruan, X.; Cacheux-Rataboul, V.; Sung, W.-K.; Tan, E.H.; Yatabe, Y.; Mano, H.; Soo, R.A. ; Chin, T.M. ; Lim, W.-T.; Ruan, Y. ; Ong, S.T.
22007Detection of epidermal growth factor receptor variations by partially denaturing HPLCChin, T.M. ; Soo, R. ; Lee, S.C.; Goh, B.C. ; Salto-Tellez, M. ; Anuar, D.; Ahmad, B.; Li, W.Q.; Iacopetta, B.; Kawakami, K.; Segal, A.
3Nov-2013EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib-letterVoon, P.J.; Tsui, D.W.Y.; Rosenfeld, N.; Chin, T.M. 
4Apr-2008Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancerWong, A.S.; Soong, R. ; Seah, S.B.-K.; Lim, S.-W. ; Chuah, K.-L.; Nga, M.-E.; Chin, T.-M. ; Soo, R.A. 
520-Oct-2009Fatal cystic change of brain metastasis after response to gefitinib in non-small-cell lung cancerZee, Y.-K.; Chin, T.-M. ; Wong, A.S.C.
6May-2011How many adenocarcinoma lung cancers come from bronchioloalveolar carcinoma?Wong, A.S.; Seto, K.-Y.; Ang, B.; Wong, E.; Chin, T.-M. ; Nga, M.-E.; Soo, R.A. 
7May-2013Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancerSudo, M.; Chin, T.M. ; Mori, S.; Doan, N.B.; Said, J.W.; Akashi, M.; Koeffler, H.P.
8Sep-2008Lung cancer response to gefitinib, then erlotinib, then gefitinib againWong, A.S.; Seto, K.-Y.; Chin, T.-M. ; Soo, R.A. 
95-Mar-2012Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometryWang, L.-Z. ; Ong, R.Y.-L.; Chin, T.-M. ; Thuya, W.-L. ; Wan, S.-C.; Wong, A.L.A.; Chan, S.-Y. ; Ho, P.C. ; Goh, B.-C.
102013Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNAMurtaza, M.; Dawson, S.-J.; Tsui, D.W.Y.; Gale, D.; Forshew, T.; Piskorz, A.M.; Parkinson, C.; Chin, S.-F.; Kingsbury, Z.; Wong, A.S.C.; Marass, F.; Humphray, S.; Hadfield, J.; Bentley, D.; Chin, T.M. ; Brenton, J.D.; Caldas, C.; Rosenfeld, N.
1115-Jul-2011Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography-tandem mass spectrometryWang, L.-Z. ; Lim, M.Y.-X.; Chin, T.-M. ; Thuya, W.-L. ; Nye, P.-L.; Wong, A.; Chan, S.-Y. ; Goh, B.-C.; Ho, P.C. 
12Aug-2012The positive impact of cytological specimens for EGFR mutation testing in non-small cell lung cancer: A single South East Asian laboratory's analysis of 670 casesPang, B.; Matthias, D.; Ong, C.W. ; Dhewar, A.N.; Gupta, S.; Lim, G.L.; Nga, M.E.; Seet, J.E.; Qasim, A.; Chin, T.M. ; Soo, R. ; Soong, R. ; Salto-Tellez, M.